Filing Details
- Accession Number:
- 0001140361-10-019977
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-10 13:00:00
- Reporting Period:
- 2010-04-30
- Filing Date:
- 2010-05-10
- Accepted Time:
- 2010-05-10 11:42:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Adherex Technologies Inc | AHX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1319998 | Southpoint Capital Advisors Lp | 623 Fifth Avenue Suite 2601 New York NY 10022 | No | No | Yes | No | |
| 1378376 | Southpoint Gp, Lp | 623 Fifth Avenue, Suite 2601 New York NY 10022 | No | No | Yes | No | |
| 1378377 | Southpoint Capital Advisors Llc | 623 Fifth Avenue, Suite 2601 New York NY 10022 | No | No | Yes | No | |
| 1378378 | Southpoint Gp, Llc | 623 Fifth Avenue, Suite 2601 New York NY 10022 | No | No | Yes | No | |
| 1378379 | Ii Smith John Clark | 623 Fifth Avenue, Suite 2601 New York NY 10022 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-04-30 | 200,000,000 | $0.00 | 241,504,000 | No | 4 | P | Indirect | See Footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Warrants (right to buy) | Acquisiton | 2010-04-30 | 200,000,000 | $0.00 | 200,000,000 | $0.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,000,000 | 2010-10-30 | 2015-04-30 | No | 4 | P | Indirect |
Footnotes
- The reported securities are included within 200,000,000 units purchased by the reporting persons for CDN$0.03 per unit. Each unit consists of one share of common stock of Adherex Technologies Inc., and one warrant to purchase one share of common stock of Adherex Technologies Inc.
- Southpoint Capital Advisors LP, and its general partner Southpoint Capital Advisors LLC, hold the reported securities indirectly on behalf of Southpoint Fund LP, Southpoint Qualified Fund LP, Southpoint Master Fund, LP and Southpoint Offshore Fund, Ltd., for which Southpoint Capital Advisors LP serves as investment manager. Southpoint GP, LP, and its general partner Southpoint GP, LLC, hold the reported securities indirectly on behalf of Southpoint Fund LP, Southpoint Qualified Fund LP, and Southpoint Master Fund, LP, of which Southpoint GP, LP is the general partner. John S. Clark II reports the securities held indirectly by Southpoint GP, LLC and Southpoint Capital Advisors LLC as the manager of each.
- Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- The exercise price of the warrants reported is listed in Canadian Dollars.
Billionaire Hedge Funds
